Patent US5080646A successfully refreshed from Google Patents.
US5080646A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Membrane for electrotransport transdermal drug delivery
Assignee: Alza Corp
•
Filing: 1988-10-03
•
Granted: 1992-01-14
•
Expires: 2008-10-03
Abstract
Abstract A membrane capable of inhibiting agent release from a delivery system when no electrical current is flowing and yet provide minimal impedance to electrically-assisted agent delivery, useful both for incorporating into electrotransport agent delivery systems and for use in measuring agent release rates in in vitro testing.
Inventors
- 👤 Felix Theeuwes
- 👤 J. Richard Gyory
- 👤 Ronald P. Haak
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-02 04:30
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/18; A61N1/20; A61N1/30; A61N1/02; A61N1/04; A61N1/0404; A61N1/0408; A61N1/0428; A61N1/0444; A61N1/0432; A61N1/044
Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
122 words
An iontophoretic agent delivery electrode assembly adapted for placement on a body surface for iontophoretic delivery of agent therethrough, the electrode assembly including an electrode, a means for connecting said electrode to a source of electrical power, and an agent reservoir containing an agent to be delivered through the body surface, the reservoir being electrically connected to the electrode, the assembly having: a membrane for controlling agent delivery from the electrode assembly, the membrane being positioned between said reservoir and said body surface, the membrane exhibiting an electrically-assisted flux (J EK ) of the agent therethrough and impeding passive flux (J P ) of the agent therethrough, the membrane exhibiting a ratio of J EK :J P of at least about 2.5.
Claim 2
Dependent Claim
122 words
An iontophoretic agent delivery electrode assembly adapted for placement on a body surface for iontophoretic delivery of agent therethrough, the electrode assembly including an electrode, a means for connecting said electrode to a source of electrical power, and an agent reservoir containing an agent to be delivered through the body surface, the reservoir being electrically connected to the electrode, the assembly having: a membrane for controlling agent delivery from the electrode assembly, the membrane being positioned between said reservoir and said body surface, the membrane exhibiting an electrically-assisted flux (J EK ) of the agent therethrough and impeding passive flux (J P ) of the agent therethrough, the membrane exhibiting a ratio of J EK :J P of at least about 2.5.
Claim 3
Dependent Claim
21 words
The electrode assembly of claim 1 wherein said membrane is comprised of a hydrophilic resin blended into a hydrophobic polymeric matrix.
Claim 4
Dependent Claim
29 words
The electrode assembly of claim 2 wherein said hydrophilic resin has a high permeability for said agent and said hydrophobic polymeric matrix has a low permeability for said agent.
Claim 5
Dependent Claim
13 words
The electrode assembly of claim 3 wherein said hydrophilic resin is cross-linked polyvinylpyrrolidone.
Claim 6
Dependent Claim
20 words
The electrode assembly of claim 4, wherein said hydrophilic resin comprises less than about 15 vol. % of the membrane.
Claim 7
Dependent Claim
15 words
The electrode assembly of claim 3 wherein said hydrophilic resin is an ion exchange resin.
Claim 8
Dependent Claim
22 words
The electrode assembly of claim 6, wherein the ion exchange resin comprises a styrene divinylbenzene lattice with paired iminodiacetate cation exchange groups.
Claim 9
Dependent Claim
19 words
The electrode assembly of claim 7, wherein the resin comprises up to about 50 vol. % of the membrane.
Claim 10
Dependent Claim
30 words
The electrode assembly of claim 6 wherein said ion exchange resin has a functional group selected from the group consisting of sulfonic acid, carboxylic acid, iminodiacetic acid, and quaternary amines.
Claim 11
Dependent Claim
35 words
The electrode assembly of claim 6, wherein the ion exchange resin is a mcaroreticular acrylic polymer based carboxylic acid cation exchange resin and the resin comprises less than about 23 vol. % of the membrane.
Claim 12
Dependent Claim
29 words
The electrode assembly of claim 3 wherein said hydrophobic polymeric matrix is an ethylene vinyl acetate copolymer having a vinyl acetate content of about 1 to 40 weight percent.
Claim 13
Dependent Claim
12 words
The electrode assembly of claim 1 wherein said agent is a macromolecule.
Claim 14
Dependent Claim
20 words
The electrode assembly of claim 12 wherein said agent is selected from the group consisting of peptides, polypeptides and proteins.
Claim 15
Dependent Claim
38 words
The electrode assembly of claim 1 wherein said agent is selected from the group consisting of metoclopramide, baclofen, betamethasone, beclomethasone, doxazosin, droperidol, fentanyl, sufentail, leuprolide, lidocaine, methotrexate, miconazole, prazosin, piroxicam, verapamil, tetracaine, dilitiazam, indomethacin, hydrocortisone, terbutaline and encainide.
Claim 16
Dependent Claim
20 words
The electrode assembly of claim 1, wherein the membrane exhibits a resistivity of less than about 10 kohm-cm 2 .
References Cited (Backward Citations)
US3797494A
Cited
US4144317A
Cited
US4274420A
Cited
US4325367A
Cited
US4391278A
Cited
US4474570A
Cited
US4419092A
Cited
US4457748A
Cited
US4640689A
Cited
US4557723A
Cited
US4622031A
Cited
US4708716A
Cited
US4904247A
Cited
US4713050A
Cited
US4702732A
Cited
US4731926A
Cited
US4673565A
Cited
US4689039A
Cited
US4722726A
Cited
US4842577A
Cited
US4731049A
Cited
US4940456A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-01-13 | 1995-07-15 | 1996-01-14 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-01-13 | 1999-07-15 | 2000-01-14 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-01-13 | 2003-07-15 | 2004-01-14 | $7700.00 | Window Closed / Lapsed |